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ABSTRACT 
15 N Nuclear Magnetic Resonance Studies of the 
Liver Alcohol Dehydrogenase-NAD+-Pyrazole Complex 
The structures of the liver alcohol dehydrogenase 
(LADH)-NAD+-pyrazole and LADH-NAD+-4-ethylpyrazole complexes 
were investigated by lSN nuclear magnetic resonance (NMR) 
spectroscopy. 15N chemical shifts were obtained for 15N-
labeled inhibitors and !SN-labeled coenzyme bound in the 
enzyme ternary complexes. The structures of the two 
inhibitor complexes were found to be very similar. 15 N 
chemical shifts of various pyrazole derivatives were 
determined. 15N NMR studies of model pyrazole derivative-
z inc chloride complexes were carried out to determine the 
effect of zinc complexation on the pyrazole N2 chemical 
shift. The Nl nicotinarnide resonance of the coenzyme of the 
LADH-NAD+-pyrazole complex was 96 ppm upfield from that of 
NAD+ in solution and only 13 ppm downfield from that of NADH 
in solution, demonstrating formation of a derivative of 
dihydronicotinamide. The lSN chemical shift of the pyrazole 
Nl of the ternary complex when compared to other pyrazole 
derivatives indicated bond formation between pyrazole Nl and 
the nicotinarnide ring of the c~enzyrne. The lSN shift of the 
v 
pyrazole Nl of the model pyrazole-NAD+ adduct, N-benzyl-1,4-
dihydro-4-pyrazolylnicotinarnide, was 5.8 ppm downfield from 
that of Nl of the enzyme ternary complex. The lSN chemical 
shift of the pyrazole N2 of the ternary complex compared to 
pyrazole derivatives in solution was shielded by more than 
40 ppm, demonstrating direct cornplexation of N2 to the 
active-site zinc. The results of model zinc complex studies 
indicated 60-100% inner-sphere coordination of the pyrazole 
N2 to the active-site zinc in the ternary complex. 
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INTRODUCTION 
I. Liver Alcohol Dehydrogenase 
Liver alcohol dehydrogenase (LADH) is a zinc-containing 
enzyme of MW about 80,000 which catalyzes the reversible 
oxidation of ethanol to ethanal in the liver.1,2 The 
reaction (Equation l) is NAD+-dependent, with equilibrium 
lying in favor of ethanol formation. 
(1) 
The reaction may be followed spectrophotometrically by 
observing the increase in absorbance at 340 nm arising from 
formation of NADH. 
The amino-acid sequence of LADH has been determined.3 
The enzyme from horse liver, which is the subject of this 
thesis, is highly homologous (about 90%) to that from human 
liver4 and less so to that from yeast.s The crystal 
structure of uncomplexed LADH has been determined to 2.4 A 
resolution6 and the crystal structures of several substrate 
or inhibitor ternary complexes with coenzyme have also been 
determined. 7- 11 
LADH is a dimer, each identical subunit being of MW 
40,000, and containing two zincs. One zinc is structural, 
liganded to four cysteine residues, Cys-97, Cys-100, Cys-
2 
Figure 1. Dimeric LADH with Bound Coenzyme (from 
reference 12). 
Figure 2. Active Site of LADH (from reference 2). 
3 
103, and Cys-111, in a distorted tetrahedral array. The 
other zinc is at the active site, liganded to two cysteines, 
Cys-46 and Cys-174, and one histidine, Bis-67, and one water 
molecule or hydroxide ion, again in a distorted tetrahedral 
arrangement. 
The dimers form a dumbbell-shaped molecule, each 
monomer unit contributing residues to each active-site 
region as illustrated in Figure 1.12 The active site has a 
non-specific substrate-binding region, capable of binding a 
variety of substrates and inhibitors in close proximity to 
both the catalytic zinc and the nicotinamide ring of bound 
coenzyme as in Figure 2.2 This substrate-binding region has 
a hydrophobic, barrel-shaped pocket extending away from the 
active-site zinc, which strongly binds substrates or 
inhibitors with long, straight alkyl chains that can extend 
into this hydrophobic barrel. 
The coenzyme-binding region consists of residues which 
bind adenosine diphosphate ribose (ADPR) in a manner similar 
to the ADPR moiety of NAD+ and NADH. NAD+ is bound more 
loosely than ADPR, indicating repulsion between the 
positively charged nicotinamide ring and active-site 
entities, probably including the active-site zinc. There is 
a conformational change upon NAD+ or NADH binding, resulting 
in reduced access of solvent to the active site. Binding of 
4 
a substrate reduces access further, resulting in a 
hydrophobic environment at the active site. The amide group 
is required for correct coenzyme binding and the subsequent 
conformational change, the pyridine ring extending away from 
the substrate-binding region, into solution, in its 
absence. 13 
Horse LADH is found to consist of a mixture of 
isozymes. There are mainly two types of monomer, each with 
different substrate specificity, the ethanol-specific 
monomer (designated "E"), and the steroid-specific monomer 
(designated "S"). The monomers themselves are not active, 
but combine to form three active isozymes, EE, SS, and ES. 
We are concerned here only with the EE isozyme, this being 
commercially available in 90% purity (based on isozyme 
content) as the crystalline suspension. 
The catalytic mechanism of LADH has been reviewed 
recently by Klinman.2 The major kinetic pathway (Figure 3) 
involves a compulsory-ordered mechanism, 1 4 with initial 
binding of coenzyme leading to a conformational change, and 
subsequent binding of substrate. Binding of NAD+ perturbs 
the pKa of a group on the enzyme from 9.2 to 7.6,15 this 
group possibly being zinc-bound water. Other zinc enzymes, 
such as carbonic anhydrase,16 and zinc complex models in 
water solutionl7 have demonstrated a large pKa change of 
5 
water upon binding to ligand-coordinated zinc. Binding of 
imidazole, demonstrated by X-ray crystallographyl8 to 
displace zinc-bound water, removes the pH-dependence of NAD+ 
binding. Direct hydride transfer has been demonstratea, 2 
although there is still debate about the precise mechanism. 
Substrate binding may involve direct coordination to the 
active-site zinc, as indicated by the X-ray results for~­
bromobenzyl alcohol binding.7 This coordination implicates 
the active-site zinc as a Lewis acid in catalysis. High-
field paramagnetic relaxation studiesl9-22 of enzyme 
substituted with cobalt for zinc have been interpreted as 
demonstrating outer-sphere coordination of substrate or 
inhibitor to the active-site metal, suggesting that metal-
bound water or hydroxide ion acts as a general acid-base 
catalyst in the LADH reaction. 
The structure of inhibitor complexes may give insight 
to the role of the active-site zinc in substrate binding and 
in catalysis. The X-ray crystal structure of the LADH-NADH-
d i rnethyl sulfoxide inhibitor complex at 2.9 A resolution 
demonstrates direct coordination of inhibitor to zinc, the 
water being displaced as the fourth ligand.a The crystal 
structures of LADH complexes of imidazole and of 1,10-
phenanthroline,18 each of which is an inhibitor with metal-
coordinating nitrogens, have demonstrated direct 
6 
coordination of inhibitor to the active-site zinc. More 
recently, the crystal structure of the LADH-NAD+-pyrazole 
complex has been published by Eklund and coworkers to 2.9 A 
resolution.9 The results again indicate direct coordination 
of pyrazole to zinc. 
II. Pyrazole 
The structure of the LADH-NAD+-pyrazole complex is 
important as a possible model for the transition-state of 
LADH-mediated NAD+ oxidation of alcohols. Pyrazole as an_ in 
il~ inhibitor of LADH is also important medically. Thus, 
pyrazole and its 4-substituted derivatives have been 
investigated for use in possible treatments of alcoholism 
and of methanol and ethylene glycol poisoning.23 
.. 
Pyrazole 4 · E't~ylpyrazole 
I II 
Pyrazole (I) was found to be a potent ethanol-
competitive inhibitor of LADH by Theorell and Yonetani in 
7 
1963.2 4 In the presence of NAO+, it forms a tight ternary 
enzyme complex with a Kr of 0.2 pM25 and a lifetime of 25 
sec at pH 7.26 A less toxic derivative of pyrazole, 4-
ethylpyrazole (II), is an even stronger inhibitor of LADH, 
with a K1 of 0.007 pM in the presence of NAD+.27 
LADH-NAD+-pyrazole complex formation is accompanied by 
the liberation of 0.8 of a proton equivalent. The complex 
crystallizes in triclinic form, similar to the LADH-NADH-
dimethyl sulfoxide complex and the binary LADH-coenzyme 
complex, while the apoenzyme crystallizes in orthorhombic 
form. The ultraviolet spectrum shows that formation of the 
LADH-NAD+-pyrazole complex is accompanied by an absorption 
increase at 290 nm, while pyrazole alone does not affect the 
LADH spectrum. This behavior is similar to that reported 
for the LADH-NAo+-NH 2 0H complex and other 1,4-
dihydronicotinamide derivatives,24,28 suggesting that the 
spectral change is caused by dihydronicotinamide formation 
in the enzyme ternary complex. 
On the basis of evidence such as the above, Theorell 
QN-li 0 .. r~ "Nl{1 
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Figure 3. Proposed Formation and Structure of the LADH-NAn+-Pyrazole Complex. 
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9 
and Yonetani proposed that Nl of pyrazole forms a covalent 
bond to C4 of the nicotinamide ring of the coenzyme in the 
ternary complex, with concurrent transfer of one equivalent 
of protons to solvent and/or enzyme residues. They also 
proposed on the basis of the zinc-complexing ability of 
pyrazole in solution, that N2 of the pyrazole derivative is 
directly coordinated to the active-site zinc atom. The 
proposed structure is shown in Figure 3. 
Crystal structures of various LADH complexes without 
pyrazole which demonstrate that the nicotinarnide ring is 
held in an orientation where the C6 side of the ring is 
di~;cted toward the substrate-binding pocket and active-site 
zinc support the proposition that addition of pyrazole to 
the nicotinarnide ring of the coenzyme should not occur at 
C2, but do also allow that addition could conceivably occur 
at C6 as well as at C4.7,8 Angelis29 has reported formation 
of a pyrazole-N-benzylnicotinamide adduct in solution with 
preferential addition at C4. It was not until recently, 
however, that proof of C4 addition in the enzyme complex was 
published. Eklund and coworkers9 have found from X-ray 
studies at 2.9 A resolution that in the crystalline LADH-
NAD+-pyrazole complex, the pyrazole Nl-nicotinamide C4 bond 
distance is 2 A. This is about one-half angstrom longer 
than expected for a covalent bond of this type, and, if not 
10 
due to experimental error, could be due to the ster ic 
constraints at the active-site of the enzyme. The pyrazole 
N2-active-site zinc atom was determined to be 2.1 A, 
indicative of inner-sphere coordination. However, Bobsein 
and Myers have interpreted 113cd chemical shifts of the 
cadmium-substituted LADH-NAD+-pyrazole complex in solution 
as demonstrating outer-sphere coordination of the inhibitor 
to the active-site zinc.30 
The possibility of inner-sphere coordination of 
inhibitor to the active-site metal in the crystalline 
complex, with outer-sphere coordination in solution has 
again been raised. Thus, it is important to study the 
structure of the native zinc-enzym~ complexes in solution. 
III. Nuclear Magnetic Resonance 
Nuclear magnetic resonance (NMR) is an important tool 
for the investigation of the structure and mechanism of 
enzymes. NMR of macromolecules presents problems usually 
not encountered in NMR of small molecules. Because the 
effective correlation time of a high-molecular-weight enzyme 
is long, both T1 , the longitudinal, and T2 , the transverse, 
relaxation times tend to be short. When T2 is short, the 
linewidths can become substantial as shown by the relation 
11 
1 
where JJ,,~ is the linewidth of the peak at half-height. This 
disadvantage is often offset by the opportunity for rapid 
pulsing allowed by short T1 relaxation times. While NMR of 
enzymes has more commonly involved the lH and 13c nuclei, 
15 N NMR31 for the study of enzymes ha~ steadily increased. 
lSN has a nuclear spin of 1/2 and thus no quadrupole moment. 
Nitrogen is comparable in importance to oxygen biologically, 
and biochemical NMR studies of nitrogen nuclei have led to 
significant findings.32 
The advantages of lSN NMR over 13c or lH NMR include 
the greater range of chemical shifts, over 900 ppm, making 
resolution and assignment of resonances easier, and a 
nuclear Overhauser effect (NOE) of -3.9. While a full NOE 
will cause an approximately 4-fold signal enhancement upon 
proton decoupling, a partial NOE can decrease or even null a 
nitrogen resonance. In such circumstances, gated proton 
decoupling is helpful to remove lH_lSN coupling without 
generating NOE. 
Other disadvantages include a low gyromagnetic ratio, 
leading to a sensitivity only 1.04 x lo-3 that of protons 
for equal numbers of nuclei and highly variable relaxation 
times. The sensitivity factor, combined with the low 
12 
natural abundance of lSN (0.37%), leads to a sensitivity at 
the natural-abundance level which is only 3.8 x io-6 that of 
protons at similar molar concentrations of protons and 
nitrogens. The sensitivity problem can be greatly 
alleviated by the use of !SN-enriched compounds. Relaxation 
times of lSN nuclei vary greatly, from very much less than 
one second to several minutes31 requiring adjustment of the 
pulse width and delay to allow observation of the slowest-
relaxing nitrogens. 
The taking of lSN NMR spectra of enzymes has until 
recently been restricted by the low concentrations 
obtainable for most large proteins. The advent of wide-bore 
spectrometers, which allows sample volumes of 18 ml or 
greater, has advanced the study of enzymes by lSN NMR at the 
natural-abundance level. In 1975, Gust, Moon, and Roberts33 
reported the natural-abundance lSN spectrum of lysozyme, an 
enzyme of MW 14,300. 
The availability of !SN-enriched compounds has also 
contributed to the wider applicability of lSN NMR to enzyme 
systems. Bachovchin and Roberts34 used lSN NMR of the 
selectively lSN-enriched histidine of OL-lytic protease to 
assist in elucidating .the catalytic mechanism. lSN-enriched 
substrates and inhibitors have allowed studies of substrate 
and inhibitor complexes of enzymes by lSN NMR. These NMR 
13 
studies using 15N-enriched samples are still limited by the 
solubility of the enzyme, millimolar concentrations being 
required. 
The greater sensitivity and resolution possible at 
higher magnetic fields has also aided the study of enzymes 
by NMR. However, higher magnetic fields may lead to 
appreciable line broadening in lSN NMR. This is because 
there may be a significant contribution to the transverse 
relaxation time T2 by chemical-shift anisotropy in lSN NMR, 
whereas in 13c NMR35 and lH NMR36 dipolar relaxation usually 
dominates. The anisotropic portion of T2 is inversely 
proportional to the square of the field37 and thus leads to 
a decrease in T2 and an increase in the linewidth as the 
field is increased. 
IV. NMB .Qf LAilli 
While no lSN NMR studies have previously been reported, 
LADH has been studied through the use of NMR of other 
nuclei, including lH, 13c, 19p and 113cd. Investigations of 
substrate- and coenzyme-LADH interactions have been made by 
determining the li~e-broadening of substrate or coenzyme 
upon exchange between bound and unbound states. Czeisler 
and Ho 11 i s 3 8 have used proton NM R o f N AD H in the presence of 
LADH to determine the lifetime of bound NADH. THe proton 
14 
NMR studies of substrate binding by LADH reported by 
Hollis39 indicate that the substrate is bound rigidly to 
LADH only in the presence of coenzyme. 
Anderson and Dahlquist40 have recently demonstrated 
through 19F NMR studies of trifluoroethanol (TFE) binding to 
LADH that biphasic kinetics are a property of a single site 
in LADH, where the other site has been inactivated by 
binding the pyrazole-NAD+ complex. This result invalidates 
the proposa141 that site-site interactions affect catalysis 
by LADH. 
Anderson and Dahlquist42 have also used fluorine NMR of 
trifluoroethanol binding to the LADH-NAD+ complex to 
determine the bound lifetimes of TFE and pyrazole in the 
LADH-NAD+-TFE and 'LADH-NAD+-pyrazole complexes at pH 8.7 (40 
sec and 400 sec, respectively). These investigators believe 
that the 19p shift of bound TFE in the LADH-NAD+-TFE complex 
does not favor TFE binding directly to the active-site zinc. 
The argument is that the 19p signal of the enzyme complex 
was shifted only slightly (0.28 ppm downfield), in the 
direction of the change in shift of TFE upon deprotonation 
(0.59 ppm downfield), whereas the fluorine resonances of the 
model adducts, (TFE)(ethyl)Zn and (TFE)(phenyl)Zn are 
shifted 1.7 and 3.4 ppm, respectively, upfield. However, 
the interpretation may be faulty, because the TFE may bind 
15 
as the alcoholate to the active-site zinc, with a partial 
cancellation of effects. The model zinc complexes may also 
be poor analogs of the zinc complex in the enzyme. Also, 
possible effects of enzyme residues must be considered. The 
authors do state that their results are consistent with the 
presence of a partial negative charge on the oxygen of bound 
TFE. 
Nuclear magnetic relaxation studies have been performed 
using LADH with cobalt substituted for both the active-site 
and structural zincs. Mildvan and coworkers20,21 have 
reported that relaxation rates of exchanging substrates and 
inhibitors indicate that these substances bind in the outer-
coordination sphere of the paramagnetic cobalt in LADH 
complexes. While their work has been criticized because the 
degree of cobalt substitution of the active-site zinc was 
questionable, Drysdale and Hollis22 used a well-
characterized, fully cobalt-substituted LADH to study the 
binding of substrates and inhibitors. Their results were in 
agreement with those of Mildvan and coworkers,43 indicating 
outer-sphere coordination of dimethyl sulf oxide and TFE to 
the LADH-NAD+-inhibitor complexes. 
These results conflict with those of X-ray 
cry st a 11 og rap hi c studies of LAD H corn pl exes, which indicate 
direct binding of ~-bromobenzyl alcohol? and dimethyl 
16 
sulfoxide8 to the active-site zinc of the LADH-NAD+-
substrate and LADH-NADH-inhibitor complexes, respectively. 
This has led to the suggestion that · the crystal structures 
may not represent the active enzyme in solution. However, 
Andersson ~.t .a.L.44 have reinvestigated the cobalt-
substituted enzyme at various field strengths. They could 
detect no paramagnetic contribution from the co 11 ions to 
the relaxation rate of solvent water and methanol protons, 
but they did find small variati~ns in the diamagnetic 
contributions at different magnetic fields which might be 
mistaken for paramagnetic effects at the high fields used in 
the previous studies. Thus, paramagnetic effects were 
suggested to be small and reinterpretation of the earlier 
high-field experiments indicated. 
Direct observation of the metal ion in the active site 
of cadmium-substituted LADH is possible by NMR because 
diamagnetic 113cd has a nuclear spin of 1/2. Bobsein and 
Myers30 have reported that trifluorethanol and pyrazole in 
the ternary LADH-NAo+-inhibi tor complexes of cadmium-
substituted LADH must bind as outer-sphere complexes, on the 
basis of identical 113cd shifts for the two complexes. This 
interpretation has been criticized? because appropriate 
model compounds have not been prepared. Bobsein and Myers45 
did interpret the chemical shift of the LADH-imidazole 
17 
complex as being indicative of inner-sphere coordination to 
the metal, even though this chemical shift is only l ppm 
downf ield from that of the pyrazole and trifluoroethanol 
complexes. The effect of pentacoordination must be 
considered, because CdII does not demonstrate as great a 
tendency for 4-coordinate over 5-coordinate complexes as 
does znII.46 
Furthermore, the complex designated by Bobsein and 
Myers30 as the LADH-NAD+ complex unexpectedly behaves like 
the LADH-NADH complex, with identical chemical shifts, 
proton-decoupling efects and pH-dependence, the pH-
dependence being that expected for the LADH-NADH binary 
complex. Only a 2-fold excess of NAD+ was used to prepare 
the LADH-NAD+ and trifluorethanol complexes and only a 1-
fold excess of NAD+ was used to prepare the LADH-NAD+-
pyrazole complex (the order of addition of pyrazole and 
coenzyme not specified). Although the authors report the 
residual ethanol content to be no more than 20% of the 
active-site concentration, these results and procedures 
suggest that perhaps the coenzyme present in these complexes 
has been reduced to NADH. Because pyrazole and 
trifluoroethanol do not form very tight complexes with NADH, 
it is not surprising that they should lead to similar 
cadmium chemical shifts, in the absence of NAD+, possibly 
18 
indicative of outer-sphere coordination. 
Even if the complexes prepared were the appropriate 
ones, with oxidized coenzyme, and if the chemical shifts are 
actually indicative of outer-sphere coordination, this is 
not proof that inner-sphere coordination of pyrazole to zinc 
in the native LADH-NAD+-pyrazole complex does not occur. 
The catalytic activity of · cadmium-substituted LADH is only 
14% that of native LADH, which fact may indicate substantial 
alteration of the transition state for hydride transfer. 46 
It is important to investigate the structure of complexes of 
the zinc-enzyme, as has been done in this thesis. 
19 
EXPERIMENTAL 
All reagents used were of reagent-grade purity unless 
otherwise specified. 
15 N2-Pyrazole (99% isotopic abundance) was prepared 
from hydrazine sulfate-lSN (Stohler, 99% isotopic abundance) 
and 1,1,3,3-tetraethoxypropane (Aldrich) by the method of 
Jones47 and subsequently purified by sublimation. 15N2-4-
Ethylpyrazole was prepared in a similar manner using 
1,1,3,3-tetraethoxy-2-ethylpropane prepared48 from 1-ethoxy-
1-butene. 4 9 [ N 1-15 N] - N AD+ was prepared from [ N 1-15 N] -
nicotinamide (90% isotopic abundance) by the method of 
Oppenheimer and Davidson.SO 
The N-methylpyrazole-zinc chloride adduct was prepared 
by the addition of one molar equivalent of zinc chloride to 
a 1.3 M aqueous solution of N-methylpyrazole at pH 6. The 
resulting precipitate was dried, dissolved in chloroform 
and, after removal of solvent, the residue had a melting 
point of 102-108°. (Found: C, 31.56; H, 4.21; Cl, 24.23; N, 
17.81; Zn, 22.35%. c 8H12 N4c1 2 zn requires: C, 31.99; H, 
4.03; Cl, 23.60; N, 18.65; Zn, 21.74%.) Ethyl 2-
pyrazolylethanoate was prepared from pyrazole and 2-
bromoethyl ethanoate by the method of Jones. 47 N-
Benzylpyrazole and N-allylpyrazole were prepared similarly 
from pyrazole and benzyl chloride or allyl bromide. N-
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carbamoyl-3-methylpyrazole and 3,5-dimethylpyrazolylmethanol 
were purchased from Aldrich and used without further 
purification. 
Zinc chloride (Ultrapure, >99% purity) was purchased 
from Alfa. 
N-Benzylnicotinamidinium chloride was prepared 
according to the method of Karrer and Stare.51 N-
Be n z y ln i k et ham id in i um chloride CN-benzyl-N,N-
diethylnicotinamidinium chloride) was prepared in a similar 
manner from N,N-diethylnicotinamide (nikethamide, Sigma). 
Pyrazole-substituted dihydronicotinamide derivatives 
were prepared by three different methods. 
M~tbQd A The model pyrazole-nicotinamide adduct N-
benzyl-l, 4-dihyd ro-4-py razolylnicotinamide was prepared at 
room temperature by the addition of a 2.0 M solution of 
sodium hydroxide to an equimolar aqueous solution of 
pyrazole and N-benzylnicotinamidinium chloride, as described 
by Angelis.29 The resultant yellow oil was extracted into 
chloroform and maintained at 0-8° to retard decomposition. 
Method ~ An aqueous solution of 2.2 H pyrazole and 2.2 
M sodium hydroxide was added to an equal volume of a 2 M 
aqueous solution of N-benzylnicotinamidinium chloride or N-
benzylnikethamidinium chloride, layered with chloroform, at 
o0 • After removal of the chloroform layer, the aqueous 
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reaction mixture was further extracted with chloroform. 
Method ~ An aqueous solution of pyrazole (40 mg, about 
0.5 mM) and sodium hydroxide (l.1 equivalents) were added to 
an - a q u e o us s o 1 u ti on of ex c es s ( 5 •fold) E -
benzylnicotinamidinium chloride, layered with chloroform at 
oo. 
LADH was purchased from Boehringer-Mannheim and 
dialyzed at 4o against O.l H phosphate buffer, pH 7.0, to 
remove residual ethanol. After addition first of pyrazole 
and subsequently of NAD+ (10-fold and 15-fold excesses, 
respectively), the solutions were concentrated by 
ultracentrifugation at 4°. The LADII-NAD+-4-ethylpyrazole 
complex was prepared from undialyzed enzyme. 
15N spectra of the ternary complex prepared f rorn 15N-
labeled pyrazole and unlabeled NAD+ were obtained on a 
Bruker WH-180 spectrometer operating at 18.25 MHz. Samples 
were contained in 25-mm tubes and were 1.1 mM (2.2 m.N) in 
enzyme. The temperature for some samples was maintained at 
12-14°. Others were at the ambient temperature. Inverse-
gated, proton-decoupled spectra were obtained in about 24 
hours using a 90°-pulse width and delay of l.S-2 sec. lSN 
spectra of the ternary complex prepared from both 15 N-
labeled pyrazole and 15N-labeled NAD+ were obtained with a 
Bruker WM-500 spectrometer operating at 50.6 8 MHz. The 
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sample was contained in a 10-mm tube and was 1.5 ml!l (3 m.m 
in enzyme. The temperature was maintained at 4°. Inverse-
g a ted, proton-decoupled spectra were obtained in about 12 
hours using a 90°-pulse width and a 5-sec delay to avoid 
overheating. 
The 15N spectrum of the ternary complex containing 15N-
labeled 4-ethylpyrazole and unlabeled NAD+ was obtained with 
the Bruker WM-500 spectrometer at ambient temperature. The 
sample was contained in a 10-mm tube and was 1 mM (2 mN) in 
concentration. An inverse-gated, proton-decoupled spectrum 
was obtained in 24 hours using a 90° pulse width and a 2-sec 
delay. 
15 N spectra of the pyrazole derivatives were obtained 
with the Bruker WH-180, Bruker WM-500 or Varian XL-200 
spectrometers using inverse-gated proton decoupling, a pulse 
width of 45°, and a delay of 15 sec. All 15N chemical 
shifts are reported in ppm upfield from external 1 M nitric 




The 15N chemical shifts of the LADH-NAo+-pyrazole 
and LADH-NAD+-4-ethylpyrazole ~omplexes are collected in 
Table 1. 
The 15N NMR spectra obtained at 18.25 MHz from the 
LADH-NAD+-pyrazole complex prepared from doubly-lSN-labeled 
pyrazole are shown in Figure 4. The observed 15N_l5N one-
bond coupling constant, lJNN' for the two nonequivalent 
pyrazole nitrogens, Nl and N2, of the complex was 10±2 Hz. 
This coupling is similar to those reported for other N-
substituted pyrazoles. Hawkes and coworkers52 report a lJNN 
of 12.8 Hz for lSN-labeled E-phenylpyrazole, which is within 
the range reported by Bulusu and coworkers,53 4.5-19 Hz. 
The linewidths for proton-decoupled Nl and N2 doublets were 
approximately 16 and 20 Hz, respectively. The spectrum of 
dialyzed enzyme complex shown in Figure 4 (b) demonstrates 
that the assigned resonances are indeed due to bound 
inhibitor which cannot be removed by dialysis. 
The sample of the ternary complex prepared from both 
doubly lSN-labeled pyrazole and lSN-labeled NAO+ gave the 
50.68 MHz spectra shown in Figure 5. The chemical shifts of 
the bound pyrazole nitrogens were identical to those found 
at 18.25 MHz, while the free pyrazole was different by +0.5 
Table 1. 15N Chemical Shiftsa of the Enzyme Ternary Complexes and the Model 
Pyrazole-NAD+ Adduct 
~ lSN 
con en Pyrazole Pyrazole 
Solute M Solvent N2 Nl ~15Nb 
LADH-NAD+-pyrazole l.lxlo-3 Buf ferc 117.8 142.1 129.95 
LADH-NAD+-4-ethylpyrazole lxl o-3 Bufferc 119.0 146.0 132.5 
Model Pyrazole-NAD+ Adduct -2 CHCl3 76.7 136.3 106.S 
(N-benzyl-1,4-dihydro-4-
pyrazolylnicotinamide, V) 
a In parts per million upfield from external 1 M nitric acid in o2o. 
b Average shift of pyrazole nitrogens. 
c 0.1 M sodium phosphate. 
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Figure 4. 15N Spectra at 18.25 MHz of LADH-NAD+-Pyrazole 
Prepared from l~N-Labeled Pyrazole. 
(a) Before dialysis, proton-decoupled (21,783 transients). 
(b) After dialysis, proton-decoupled (27,007 transients). 
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Fiygre 5. 15N Spectra at 50.68 MHz of LADH-NAD+-Pyrazole Prepared from 
N-Labeled Pyrazole and NAO+. (a) Before dialysis, proton-coupled, 
no delay between 90° pulses (43,000 transients) (b) After dialysis, 
proton-decoupled (5,725 transients). 
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f~gure 6. 15N Spectrum at 50.68 MHz of LADU-NAD+-4-Ethylpyrazole Prepared from 
N-Labeled 4-Ethylpyrazole. Undialyzed, proton-decoupled (74,356 transients), 




ppm. At the higher field, 50.6 8 ~~.t:.Sll.S 18.25 MHz, the 15N-
15N coupling of the pyrazole nitrogens was unresolved, Nl 
and N2 each being broadened to about 25 and 30 Hz, 
re_spectively, in the proton-decoupled spectrum. This 
broadening is likely to be the consequence either of 
increases in relaxation rate associated with chemical-shift 
anisotropy or of chemical exchange. The chemical shift of 
the nicotinamide ring nitrogen (Nl) of the coenzyme in the 
ternary complex is 96 ppm upfield from that of NAD+ in 
solution,SO which fact indicates dihydronicotinamide 
formation, as will be discussed later. The observed 
linewidth for this nicotinamide nitrogen in the decoupled 
spectrum was about 5 Hz. Again, the spectrum obtained after 
dialysis (see Figure 5 (b)) demonstrates that these 
resonances are due to bound inhibitor and coenzyme. 
The sample of LADH-NAD+-4-ethylpyrazole complex 
prepared from doubly lSN-labeled 4-ethylpyrazole and 
u n 1abe1 e d N AD+ gave the 1 5 N spec t rum at 5 O. 6 8 M Hz s how n in 
Figure 6. The ternary complex was prepared from undialyzed 
enzyme which contained residual ethanol. This, however, 
should be irrelevant because 4-ethylpyrazole (added in large 
excess to the enzyme before the addition of excess NAD+) in 
the presence of NAD+ displaces ethanol completely. The 
chemical shifts for the bound pyrazole nitrogens, Nl and N2, 
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were 146.0 and 119.0 ppm, respectively, while the chemical 
shift for the unbound 4-ethylpyrazole was 133.6 ppm. The 
15 N one-bond coupling was unresolved because of line 
br.oadening, as in the earlier 50.68 MHz spectra. The 
linewidths for the Nl and N2 resonances were about 20 and 40 
Hz, respectively. The operating conditions used to obtain 
the inverse-gated proton-decoupled spectrum for this complex 
were slightly different from those used for previous 
complexes, with a shorter delay time between pulses. This 
apparently led to an inverted free 4-ethylpyrazole resonance 
as the result of some residual NOE. 
Also apparent in the spectra obtained from these 
ternary complexes is the broad resonance at about 255 ppm 
which can be assigned to the backbone amide nitrogens of the 
enzyme. 







solute Rl M solvent N2 Nl £15Nb Reference 
Pyrazole (I) -H 2 H20 132.8 54 
5 CH3CN 12"5.5 this work 




3 H2o 132.l this work 
-H lOxlo-3 Buffer 132.0 this work 
4-Ethylpyrazole (II) -H lOxlo-3 Buff er 133.6 this work 
N-Methylpyrazole (III) -H 2 CHC13 70. 3 174.6 122.45 54 
N-Benzylpyrazole -CH2c6H5 n_efil 68.9 162.8 115.85 this work 
2 CH3CN 67.3 161.5 114.4 this work 
(continued) 
Table 2, continued: 
~ 15N 
concn · 
solute RI M solvent N2 Nl ~15Nb Reference 
Ethyl 2-pyrazolyl- -cn2cooc2u5 2 CH3CN 66.4 173.3 119.85 this work ethanoate (IV) 
2 (CH3) 2so 65.4 172.7 119.05 this work 
N-Allylpyrazole -CH2CH=CH2 n~_g.t. 68.9 162.8 115.85 this work 
3 c2n5on 76.7 167.3 122.0 this work 
N-Carbamoyl- -CONH2 3 (CH3) 2so 81.2 152.6 116.9 this work w 3-methylpyrazole ..., 
3,5-Dimethylpyrazole -H 2 CHC1 3 133.6 54 
3,5-Dimethyl- -CH20H 2 (CH3)2SO 73.4 156.6 115.0 this work 
pyrazolylmethanol 
N-Benzyl-1,4-dihydro- -2 CHCl3 76.7 136.3 106.5 this work 
pyrazolyl-
nicotinamide (V) 
a In parts per million upfield from external 1 M nitric acid in o2o. 







For comparison with the lSN shifts of the pyrazoles in 
the enzyme complex, the corresponding lSN chemical shifts of 
several pyrazole derivatives were determined (Table 2). The 
pyrazole-nicotinamide adduct CE-benzyl-l,4-dihydro-4-
pyrazolylnicotinamide, V), which provides a model for the 
pyrazole-NAD+ adduct, was prepared by addition of sodium 
hydroxide to a mixture of pyrazole and li-
benzylnicotinamidinium chloride (VI). This adduct has been 
reported by Angelis to be the C4 addition product and to 
have a half-life of about one hour at room temperature. 29 
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We observed little decomposition at 7-8° during the ten 
hours required to obtain a natural-abundance spectrum. When 
the reaction conditions were altered as in Method B or C of 
the experimental section, more than one pyrazole derivative 
was formed, possibly due to polymerization or addition of 
pyrazole to C2 or C6 of the nicotinamide ring. The 
substances in these mixtures were too unstable to be 
isolated and were not characterized further. However, the 
ultraviolet absorption spectra of the product mixtures with 
maximum absorbances of about 320 nm are characteristic of 
1,4-dihydronicotinamide derivatives {see Table 3). Any 
hydroxide-nicotinamide addition products present in the 
mixture would also affect the absorption spectra. Dittmer 
and Kolyer55 have reported the formation of a 1,4-
dihydronicotinamide product with a maximum absorbance of 
330-335 nm, upon addition of sodium hydroxide to D-
benzylnicotinamidinium chloride, which they proposed to be a 
dimolecular ether, bridged at the 4-positions of the two 
dihydronicotinamide moieties. 
The lSN chemical shifts of products from each of the 
methods of carrying out the reaction are shown in Table 4. 
Reaction products of pyrazole and nicotinamidinium ions 
are the only pyrazole ·derivatives for which the Nl chemical 
Table 3. Ultraviolet Absorption Maxima of Dihydronicotinamide Derivatives. 
Coenzyme or Amax (nm) Amax (nm) 
Complexing Agent Coenzyme non-enzymic LADH solvent Reference 
Analog complex complex 
-




nicotinamidiniurn --- CHCl3 this work 
chloride 
N-Benzyl-
318b nicotinarnidiniurn --- CHCl3 this work 
chloride 
N-Benzyl-




nicotinarnidinium 315 --- aqueous 24 
chloride 
Irnidazole NAO+ 305 --- aqueous 28a 
N-Benzyl-
nicotinarnidinium 315 --- aqueous 28a 
chloride 
Hydroxylarnine NAO+ 315 300 aqueous 28b 
N-Methyl-
nicotinarnidinium 330 --- aqueous 24 
chloride 
Cyanide NAO+ 325 310 aqueous 28b 
a Prepared by Method A (Experimental Section). 
b Prepared by Method B (Experimental Section). 




Table 4. 15N Chemical Shiftsa of Reaction Products of 
Pyrazole and N-Benzylnicotinamidiniurn Chloride VI or N-
Benzylnikethamidiniurn Chloride in Chloroform 
Reactants 




15N-Labeled Pyrazole + VI B 
Major products(-70% yield) 75.9 
Minor products(-20% yield) 74.0 
(-10% yield) 7 2. 3 
Pyrazole + N-Benzyl- c 
nikethamidinium chloride 
(-50% yield) 76.6 








a In parts per million upfield from external 1 M nitric 
acid in n2o. 
b See Experimental Section. 
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shifts have been found to be close to those of the enzyme 
complex. The N2 shift of the pyrazole-nicotinamide model 
adduct, as for all other pyrazole derivatives investigated, 
is considerably downf ield from the N2 shift of the enzyme 
complex. The lSN_lSN one-bond coupling constants for 
reaction products of !SN-labeled pyrazole and .tj-
benzylnicotinamidinium chloride were all about 13 Hz {see 
Table 4), similar to the lSN_lSN one-bond coupling constant 
of abo~t 10 Hz found for the LADH-NAD+-pyrazole complex. 
M~ Pyrazole-Zinc .c,Qmplexes 
The effects of complexation with zinc chloride on the 
chemical shifts of the nitrogens of pyrazole and some of its 
derivatives are summarized in Tables 5 and 6. The N-
methylpyrazole (III)-zinc chloride adduct (IX) which we 
have prepared has the empirical formula of (~­
methylpyrazole)2znc12 as determined by atomic analysis. The 
complex is insoluble in water, but soluble in chloroform and 
acetone. The pyrazole derivative, ethyl 2-
pyrazolylethanoate (IV),_ was chosen as a model for zinc 
binding in the enzyme-inhibitor complex, because it was 
expected that the ester carbonyl group would enhance 
complexation of zinc chloride to N2 of the pyrazole ring. 
Table 5. 15N Chemical Shiftsa of Zinc Complexes of Pyrazole 
and Pyrazole Derivatives 
concnb 
f> lSN /J ~ 15Nc 
------
Solute Ratiod Solvent M Nl N2 Nl 
Pyrazole + ZnC12 2:1 CH3CN 3 148.2e 
1:1 (CH3) 2so 1 13 8.1 e 
N-~ethylpyrazole2 zncl2 2:1 CHC13 0.4 175.9 121.1 +1.3 
Ethyl 2-pyrazolylethanoate 2:1.5 CH3CN 2 175.6 121.3 +2.3 
+ ZnC12 
a In parts per million upfield from external 1 M nitric acid in n2o. 
b Concentration of pyrazole derivative. 
c Change in chemical shift relative to uncomplexed compound (Table 2). 
d Molar Ratio of pyrazole derivative to zinc chloride. 






f Approximate change in shift based on change in average shift of +22.7 ppm. 







Effects of Zinc Complexation on lSN Chemical 



























































a In parts per million upfield from external 1 M nitric acid 
in o2o. 
b Molar ratio of ethyl 2-pyrazolylethanoate to zinc chloride. 
c Change in chemical shift relative to uncomplexed compound. 
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Complexing of IV with zinc chloride was found to be solvent-
dependent. Dimethyl sulfoxide, which complexes well with 
zinc chloride, competes effectively with the pyrazole 
derivative for zinc, thus producing a smaller pyrazole N2 
shift on saturation with zinc chloride (at a molar ratio of 
2:4.5, IV:zinc chloride). Acetonitrile as solvent produced 
a larger pyrazole N2 shift than dimethyl sulf oxide on 
saturating a pyrazole solution with zinc chloride (2:1.5 
molar ratio, IV:zinc chloride) than was observed at 
saturation with zinc chloride in dimethyl sulfoxide. 
Addition of smaller amounts of zinc chloride produced 
smaller shifts (Table 6). Only one pyrazole N2 resonance 
was observed in all cases, indicating fast exchange between 
complexed and uncomplexed states. For both solvents, the 
solubility of zinc chloride was many-fold higher in the 
presence of the pyrazole derivative than in neat solvent. 
Other pyrazole derivatives were investigated for zinc-
complexing ability, but either showed reduced complexation 
as exemplified by smaller changes in chemical shift or 
produced zinc complexes of too low solubility for 15N NMR 
spectra to be obtained. At saturation Cl M concentration 
zinc chloride) with zinc chloride of 2 M ~-carbamoyl-3-
methylpyrazole in dimethyl sulf oxide, the upfield shift of 
Nl was 0.5 ppm, while the upfield shift of N2 was only 0.4 
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ppm, relative to 3 M N-carbamoyl-3-methylpyrazole. This 
could be indicative of zinc complexation by the carboxamide 
group with little or no complexation by N2 of the pyrazole 
nucleus, or simply concentration effects, the pyrazole 
nitrogen shifts being affected by changes in the degree of 
intermolecular hydrogen bonding. 
When neat ethyl 2-pyrazolylethanoate, (IV), is heated 
with 0.25 equivalents zinc chloride for 2 hours at 75°, the 
zinc chloride almost completely dissolves, producing a rose-
col ored solution similar to that of the ethyl 2-
pyrazolylethanoate-zinc chloride complex in dimethyl 
sulfoxide. The N2 and Nl chemical shifts for this complex 
were found to be 88.8 and 175.0 ppm, respectively. The 
upfield shift change of about 20 ppm for N2 is a little less 
than half that found for addition of 0.5 equivalents zinc 




'The lSN NMR spectra of the LADH-NAD+-pyrazole and LADH-
NAD+-4-ethylpyrazole complexes are shown in Figures 4, 5 and 
6. The assignment of resonances by analogy to the lSN 
resonances of other pyrazoles and NADH is unambiguous. This 
is the largest enzyme compiex for which lSN spectra have so 
far been reported. The resonances are much sharper than 
might be predicted for a complex of MW greater than 80,000. 
II. Coeozym~ 
The chemical shift of the nicotinamide ring nitrogen of 
the coenzyme in the ternary complex, 247.2 ppm, demonstrates 
that the coenzyme in the LADB-NAD+-pyrazole complex has the 
dihydro structure (Equation 2). 
0 








The upfield shift resulting from complex formation was 96 
ppm relative to free NAD+, and is comparable to the upfield 
change in shift in solution of 109 ppm that has been 
reported for reduction of NAD+ to NADH. 50 
The lSN chemical shift is wholly consistent with 
addition of pyrazole to C4 of the nicotinarnide ring, as 
proposed by Theorell and Yonetani.24 However, from the lSN 
shift of the nicotinamide Nl alone, it cannot be determined 
at which position addition has occurred. The resonance is 
13 ppm downf ield from that of NADH in solution, and it is 
possible that this is a large enough difference to indicate 
that addition has occurred at either C2 or C6. In which 
case, the lSN-labeled pyrazole Nl would be removed from the 
nicotinamide Nl by only one carbon atom (Figure 7), and the 
13 ppm deshielding of the nicotinamide Nl would be 
attributable to the proximity of the electron-withdrawing 
pyrazole nucleus. 
44 





Pro31"ct oJ Cb ~~ition 
Figure 7. Other Possible Products of Pyrazole Addi ti on to 
NAD+. 
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In all complexes studied so far, the conformation of 
bound coenzyme as determined by X-ray crystallography 
effectively rules out addition at C2, the nicotinamide ring 
being bound with the C6 side of the nicotinamide ring 
towards the substrate-binding region. Crystallographic 
studies9 of the LADH-NAD+-pyrazole complex give a pyrazole 
Nl-nicotinarnide C4 bond distance of 2 A, with Nl-C6 
distances being much greater. Clearly, considerable 
rearrangement of the crystalline active-site structure would 
be necessary to allow Nl-C6 bond formation in solution. 
Substitution of the C4 hydrogen of NADH by the more 
electronegative nitrogen of pyrazole might alone account for 
the downf ield shift relative to NADH through a diamagnetic 
deshielding effect. 13c NMR chemical shifts (Table 7) of 
the pyrazole-nicotinarnide adduct V, and .N-benzyl-1,4-
dihydronicotinamide VII, as reported by Angelis, 29 
demonstrate the deshielding effect of pyrazole substitution 
on the nicotinamide ring carbons, whose 13c resonances are 
all shifted downf ield in the pyrazole-nicotinarnide adduct 
relative to N-benzyl-1,4-dihydronicotinarnide. Steric and 
electronic effects of active-site residues probably also 
contribute to the shift difference, though their effect on 
NADH in the binary LADH-coenzyme complex has not been 
determined. 
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Table 7. 13c NMR Chemical Shiftsa of the Model Pyrazole-
NAO+ Adduct, N-Benzyl-1,4-dihydro-4-pyrazolylnicotinamide V, 
and N-Benzyl-1,4-dihydronicotinamide vn.29 
Carbon v VII vn-vb 
C2 139.2 139.0 - 0.2 
C3 102. 8 98.9 - 3.9 
C4 54.8 22.7 -32.1 
cs 106.8 103.2 - 3.6 
C6 130.9 129.0 - 1.9 
C7 169.S 17 o. 3 + 0.8 
a In parts per million downfield from TMS. 
b Negative values of vn-v indicate deshielding of V 
relative to VIL 
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Oppenheimer and DavidsonSO have found little or no 
solvent effect on the lSN chemical shifts of Nl of NAO+ and 
NADH. Their results indicate that the degree of 
hydrophobicity of residues surrounding the bound coenzyme 
should not exert much effect on the Nl chemical shift. 
There is, however, a large effect on the chemical shift 
caused by a change of electronic state of Nl of nicotinarnide 
derivatives, the resonance shifting about; 100 ppm upfield 
upon formation of the dihydro derivative. Formally, Nl 
changes hybridization state from sp2 to sp3 with concurrent 
loss of aromaticity and charge upon dihydro derivative 
formation. However, Oppenheimer, Arnold and Kaplan56 have 
proposed on the basis of proton NMR results that NADH in 
solution is in fast exchange between a conformation where 
the nicotinamide ring is planar and a conformation where the 
nicotinamide ring is puckered, but still planar at Nl, 
equilibrium favoring the planar nicotinamide ring. 
Crystallographic studies57 of ~-benzyl-1,4-
dihydronicotinamide have demonstrated that the ring is 
planar. The observation of absorption at 340 nm for NADH and 
at similar wavelengths for other dihydronicotinamide 
derivatives (see Table 3) again indicates planarity at Nl, 
to allow the electronic transition to the resonance form 
(VIII) responsible for the absorption (Figure 8). The 
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hybridization state of Nl of the dihydronicotinamide ring 
can therefore be described as more sp2-like than sp3-like. 
c • 
VIII 
Figure 8. Resonance Forms of NADH. 
It is possible that the coenzyme-binding region of the 
enzyme induces a change in the geometry of the nicotinarnide 
moiety of the coenzyme upon binding. A 10-15 nm shift to 
shorter wavelength in the maximum absorbance of the 
absorption spectrum of dihydronicotinamide derivatives is 
seen upon binding to LADH (Table 3). This wavelength 
decrease corresponds to an increase in energy for the 
transition shown in Figure 8. This could conceivably be 
associated with a deviation from planarity by the 
nicotinamide ring. Cook, Oppenheimer and Cleland have 
proposed, on the basis of secondary isotope effects in the 
reaction of [N1-lSN]-labeled coenzyme and cyclohexanone or 
cyclohexanol with LADa,58 that in the transition state, the 
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nicotinamide ring is bent into a boat-like conformation, 
facilitating the reaction by increasing the reactivity of 
C4. They suggest that this is brought about by a change in 
conformation of the enzyme. Binding of coenzyme does induce 
a conformational change,59 and it has been shown that the 
amide group of the nicotinamide ring is necessary for this 
change to occur.60 Both LADH-NADH-dimethyl sulfoxide8 and 
LADH-NAD+-pyrazole9 complexes crystallize in triclinic form, 
with approximately the same enzyme conformation, which is 
different from the uncomplexed LADH or LADH-ADPR 
conformations. In these crystalline complexes, the 
nicotinarnide ring of the coenzyme is planar. If the LADH-
NAD+-pyrazole complex may be viewed as a transition-state 
analog, the crystallographic determination of the geometry 
of the nicotinamide ring disproves the proposal by Cook and 
coworkers that the transition state involves a pyramidal 
nicotinarnide Nl. 
The lSN chemical shifts reported here for the ternary 
complex in solution also do not support this hypothesis, the 
nicotinamide chemical shift being close to that of 
dihydronicotinamides in solution, but shifted in the 
direction of less shielding. An increase in the p-character 
of Nl as caused by deviation from planarity to produce a 
pyramidal Nl should cause an increase in shielding, i.e., an 
so 
upfield shift, because of decreases in lone-pair 
delocalization. 
The nicotinamide nitrogen chemical shift thus indicates 
that the state of the coenzyme in the LADH-NAD+-pyrazole 
complex in solution is similar to that found in the 
crystalline complex.9 Together with the Nl pyrazole 
chemical shifts, which will be discussed later, these 
results demonstrate that in the active site of the enzyme, 
pyrazole adds to the nicotinamide ring of the coenzyme, 
producing the dihydronicotinamide form of the coenzyme. 
III. Pyrazole 
I I I.l. Introduction 
Pyrazole is a five-membered aromatic heterocycle with 
two adjacent ring nitrogens {structure I). The chemistry of 
pyrazoles has been reviewed by Kost and Grandberg.61 The 
pyrazole nucleus is generally quite stable. Much of the 
chemistr¥ of pyrazole concerns reactions involving the 
labile N-H bond. The hydrogen at Nl is easily replaced by 
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Figure 9. Acid-Base Behavior of Pyrazole 
The presence of two types of nitrogens, one pyrrole-
type, Nl, and one pyridine-type, N2, explains the 
amphoteric behavior of pyrazole. Neutral pyrazole loses a 
proton to form the pyrazolide anion, as in Figure 9, with a 
pKa greater than 14.62 The protonated form of pyrazole, 
the pyrazolium ion, loses a proton as in Figure 9, with a 
pKa of 2.5. 
The solubility of pyrazole in most solvents is quite 
high. This has allowed the lSN NMR of pyrazoles to be 
studied at the natural-abundance level. However, the 
solubility of LADH complexes is on the millimolar level, 
making natural-abundance lSN NMR studies of inhibitor bound 
S2 
to LADH infeasible. Howevever, the ready availability of 
!SN-labeled hydrazine permits facile preparation of doubly-
lSN-labeled pyrazole and 'pyrazole derivatives and NMR 
spectra of !SN-labeled pyrazoles may be obtained at 
millimolar concentrations. The result is that it is quite 
feasible to make lSN studies of the LADH-NAD+-lSN-labeled 
pyrazole complex. 
III.2. lSN NMR Qf Pyrazole 
lSN chemical shifts of several pyrazoles are given in 
Table 2. Pyrazole (I), in aqueous solution gives rise to a • 
single lSN resonance. This is the result of a fast 
tautomeric equilibration involving the pyrrole-type, Nl, and 









Under conditions where the exchange of the proton between 
the two nitrcgens is fast on the NMR time scale, only one 
average resonance is observed. The chemical shift of this 
resonance is the average of the individual shifts for the 
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two tautomers. The averaging process is not quite complete 
because addition of a small amount of base or acid can 
sharpen the resonance, by catalyzing tautomeric 
equilibration. 
· The exchange rate between the two tautomers is 
approaching a rate which · is intermediate on the NMR time 
scale when exchange broadening occurs, and should be 
comparable t.o 2 f( times the shift c1iff erence in Hertz, where 
the shift difference in Hertz is the frequency of the 
spectrometer times the shift difference between the two 
nitrogen resonances in the absence of exchange. This shift 
difference is 92 ppm, based on the shifts of the two 
nitrogens in dimethyl sulfoxide (Table 2). The rate of 
tautomeric equilibration in aqueous solution where exchange 
broadening is occurring is thus on the order of 1.1 x 104 
sec-1 • 
Pyrazole in dimethyl sulfoxide solution gives rise to 
two separate, broad lSN resonances because in this solvent 
tautomeric equilibration is slow. In acetonitrile solution, 
it is sometimes difficult to obtain any signal at all from 
samples 1-2 M in concentration, an indication of 
intermediate exchange rates, with the resonances so 
broadened as to be indistinguishable f rorn the baseline. A 
broad averaged signal was obtained from a 5 H solution of 
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pyrazole in acetonitrile (Table 2). Here, tautomeric 
equilibration was clearly accelerated, perhaps by a 
concentration-dependent increase in intermolecular proton 
transfer or by traces of water in the sample. 
Protonation and hydrogen bonding effects on the 
chemical shift of pyrazole derivatives have been 
investigated by Schuster, Dyllick-Brenzinger and Roberts.54 
Protonation of pyrazole to form the pyrazolium ion causes 
an upfield shift of 45.9 ppm for the averaged nitrogens. 
The effect of protonation of N2 on the individual nitrogen 
resonances is seen in N-substituted pyrazoles. Substitution 
at Nl prevents tautomeric equilibration of the two nitrogens 
of the pyrazole nucleus. Thus, individual resonances for 
the two non-equivalent nitrogens can be obtained for N-
substituted pyrazoles even in aqueous solution. Protonation 
of N-methylpyrazole results in a 100-ppm upfield shift of 
N2, because of the removal of the paramagnetic deshielding 
associated with the n--+ 11' * transition in the neutral 
compound. Protonation affects the Nl chemical shift to a 
much lesser degree, there being an upfield shift of 4 ppm. 
Increases in hydrogen bonding cause substantial upfield 
shifts of N2 as well as small upfield shifts of Nl. The 
maximum shift associated with hydrogen bonding of N2 of 
pyrazole derivatives may be approximated by the shift of 
SS 
+17.9 ppm for N2 of N-methylpyrazole upon change of solvent 
from chloroform to trifluoroethanol. Here, the 
corresponding change in the Nl resonance is upfield by 1.4 
ppm.54 
Deprotonation of neutral pyrazole to form the 
pyrazolide anion causes a downf ield shift in the averaged 
resonance. The chemical shift of pyrazole decreases upon 
increase of pH above pH 12, to a value of 80 ppm at pH 15.2, 
consistent with a pKa of greater than 13.7, as determined by 
titrations by Kanamori.63 This downf ield shift is caused by 
an increase in the paramagnetic deshielding of Nl upon loss 
of the proton. The most downf ield 15N shift so far observed 
for a pyrazole derivative is SS.1 ppm, found for 5 mM 15N-
labeled pyrazole in dimethyl sulfoxide after addition of 
excess sodium hydride. It was not determined whether this 
averaged signal was the result of fast proton exchange 
between the pyrazolide anion and any neutral pyrazole still 
present in solution as the result of incomplete anion 
formation. 
Pyrazoles 
The 15N chemical shifts of various pyrazole derivatives 
(Table 2) were determined for comparison with the enzyme 
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complex. The chemical shift of the pyrrole-type nitrogen Nl 
of pyrazole derivatives depends considerably on the nature 
of the Nl substituent. All E-substituted pyrazole 
derivatives stable at room temperature which were 
investigated have Nl shifts greater than 150 ppm, the most 
shielded being that of N-methylpyrazole at 17 4.6 ppm, which 
has the electron-releasing methyl group as a substituent. 
The Nl chemical shifts of derivatives with the strongly 
electron-withdrawing substituents, -CONH2 , and -cH2oH, 
were the most downfield, at 152.6 and 156.6 ppm, 
respectively, in dimethyl sulfoxide, but were still more 
than 10 ppm upfield from the Nl chemical shifts of the LADH-
NAD+-pyrazole complex. 
The only pyrazole derivatives found so far that have Nl 
chemical shifts close to that found for the enzyme ternary 
complex are the pyrazole-nicotinamidinium ion reaction 
products (Table 4). B-Benzyl-1,4-dihydro-4-
pyrazolylnicotinamide (V) was prepared to serve as a model 
for the pyrazole-NAD+ adduct of the enzyme inhibitor 
complex. Angelis has reported that in this adduct, the site 
of addition of pyrazole to nicotinamide is at C4. The Nl 
chemical shift for this adduct, 136.3 ppm in chloroform, is 
5.8 ppm downfield from that of the LADH-NAD+-pyrazole 
complex, indicating that the dihydronicotinamide moiety has 
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a much larger deshielding effect than the other Nl 
substituents investigated. The model pyrazole-NAD+ adduct V 
was prepared by the method of Angelis29 by the addition of 
base to an equimolar mixture of pyrazole and E-
benzylnicotinamidinium chloride in water (Figure 10). The 
chemical shifts of the pyrazole nitrogens of this compound 
provide a good point of reference for the interpretation of 
the chemical shifts of the enzyme complex. The fact that Nl 
is unusually deshielded compared to other pyrazole 
derivatives may be attributed to the particular effect of 
the dihydronicotinamide moiety, as evidenced by the chemical 
shifts of other pyrazole-nicotinamide complexes. When the 
reaction conditions for pyrazole addition to H-
benzylnicotinamidinium chloride are altered (see 
Experimental Section), other minor (about 30% yield), as yet 
un identified, pyrazol e derivatives are for med. These 
pyrazole-nicotinamide reaction products have nitrogen shifts 
close to those of V (see Table 4). These may be the 
products of C2 and C6 addition of pyrazole to the 
nicotinamide ring or of polymerization. Addition of 
hydroxide to H-benzylnicotinamidinium chloride results in 
the formation of dimers and trimers of E-
benzyldihydronicotinamide.55,64 This suggests that polymers 
of E-benzyl-1,4-dihydro-4-pyrazolylnicotinamide may also be 
59 
formed, with structures similar to those proposed for the 
hydroxide polymerization products, that is, where the 
dihydronicotinamide rings are bridged through C2, C4 or C6 
and the amide nitrogen or the benzyl methylene carbon. 
Because both the Nl and N2 chemical shifts are similar to V 
and the Nl chemical shifts are considerably different from 
other pyrazole derivative~ with the exception of the enzyme 
complex, it may be assumed that these chemical shifts are 
characteristic of dihydronicotinamide substitution at Nl of 
the pyrazole ring. 
The chemical shifts of the pyridine-type N2 nitrogens 
of pyrazole derivatives in non-hydrogen-bonding solvents 
were found to be in the range of 65.4-76.7 ppm, with the 
exception of B-carbamoyl-3-methylpyrazole. The N2 chemical 
shift .of this derivative, 81.2 ppm, is more shielded than 
the others, possibly because of intermolecular hydrogen 
bonding between N2 and the amide -NH 2 group of the 
substituent in the fairly concentrated (3 .tl) solution used 
for the chemical-shift determinations. 
The N2 resonance of the model pyrazole-NAD+ adduct, V, 
is the most upfield of those found for the other pyrazole 
derivatives, yet it is 41.1 ppm downf ield from N2 of the 
enzyme ternary complex. This shift difference seems much 
larger than can be attributed to hydrogen bonding (about 18 
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ppm54 ) and strongly suggests complexation of N2 of pyrazole 
in the enzyme complex by the active-site zinc. 
I I I. 4 15 N .Cb.e mi~.al .Shift.~ .Qf M.QQ..el ~~.r.2.z.2l.e::.Z.in~ 
Complexes 
The effects of metal complexation on the 15N chemical 
shifts of pyrazole comp-0unds have not previously been 
reported, but there are accounts of the effect of zinc 
comFlexation on the 15N chemical shifts of the pyridine-type 
nitrogens of other compounds. 
Alei and coworkers have investigated zinc-cornplexation 
effects on the chemical shift of the pyridine-type N3 
nitrogen of imidazole65 and N-methylimidazole66 in aqueous 
solution. They found an upfield shift of 11-17 ppm for the 
averaged nitrogen resonances of zinc-complexed irnidazole, 
which is less than half that due to protonation. The actual 
effect on N3 is difficult to determine because of fast 
tautorneric exchange of the two nitrogens. However, this 
average shift may be interpreted as 25-40 ppm upfield shift 
of the pyridine-type nitrogen upon zinc complexation, by 
analogy to N-methylimidazole, whose N3 nitrogen on zinc 
complexation moves upfield by +35-40 ppm. This is about 
half the shift, +73 ppm, caused by protonation of N3. The Nl 
resonance was found to shift downf ield by 3-5 ppm. 
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The effect of zinc complexation on the 15N chemical 
shifts of several nucleosides at natural abundance. was 
investigated by Buchanan and Stothers.67 The observed lSN 
resonances were most likely averaged resonances of 
uncomplexed nucleoside and two or more forms of zinc-
complexed nucleoside, and therefore the shifts were by no 
means surely the maximum possible on full zinc complexation. 
On addition of equimolar zinc nitrate to 0.5 M 
adenosine in dimethyl sulfoxide, the N7 resonance shifted 
upfield 7.5 ppm relative to uncomplexed adenosine. The Nl 
resonance shifted 1.6 ppm upfield, which indicates a lesser 
degree of zinc complexation to Nl than N7. Protonation of 
Nl results in a 72.6 ppm upfield shift of Nl. These results 
suggest that the major site of zinc complexation of 
adenosine is N7, as illustrated in Figure ll(a), even though 
protonation occurs at Nl. 
On addition of equimolar zinc nitrate to 0.75 M 
cytidine in dimethyl sulf oxide, N3 was observed to shift 
upfield 22 ppm, while Nl shifted upfield only 2 ppm. Here, 
the major site of zinc complexation is N3, with lesser 
complexation to Nl. This is similar to what is observed on 
protonation, which also occurs at N3, but the protonation 
shift is +64.8 ppm for N3. The larger upfield shifts for 
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Figure 11. Propg~ed Sites of Zinc Complexation of Several 
Nucleosides. (a) Zinc complex of adenosine. 
(b) Zinc complex of cytidine. (c) Zinc complex of 
guanosine. 
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cytidine than for adenosine speak for fuller zinc 
complexation as the result of stabilization of the N3-zinc 
complex by simultaneous coordination to the carbonyl group, 
as illustrated in Figure ll(b). The effect of zinc 
cornplexation on the lSN chemical shifts of guanosine was 
similar to that found for cytidine, which indicates the 
major site of zinc complexation to be at N7, probably 
bidentate with the carbonyl as illustrated in Figure 
ll(c).67 
Happes and Morales68 determined the lSN shifts caused 
by zinc complexation of adenosine S'-triphosphate, ATP, in 
o2o solution. N7 was found to shift upfield 3 ppm upon 
addition of equimolar zinc chloride. This is a much 
smaller shift than that found for adenosine by Buchanan and 
Stothers,67 but indicates a s·imilar complexation of zinc to 
N7. 
Based on these reports of the effects of zinc-
complexation on the lSN chemical shifts of pyridine-type 
nitrogens (up to +40 ppm changes), it could be predicted 
that N2 of pyrazole and its derivatives would shift upfield 
upon complexation to zinc. However, the magnitude of the 
shift arising from full zinc complexation could hardly be 
predicted. The magnitude is very important, so that the 
full complexation shift may be compared to the shift 
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demonstrated by the enzyme complex and allow the extent of 
direct zinc complexation in the enzyme complex to be 
determined. 
The lSN chemical shifts of various model pyrazole-zinc 
complexes are collected in Table 5. Zinc complexation of N2 
(the pyridine-type nitrogen) of pyrazole as expected causes 
an upfield shift, just as does protonation of N2. The reason 
is that coordination to zinc (or a proton) greatly decreases 
the paramagnetic deshielding which can be ascribed to an 
increase in the mixing in of excited states into the ground 
state corresponding to the n---+-r<* transition of neutral 
pyrazole when the pyrazole is placed in a magnetic field. 
Complexing of then electrons with zinc or a proton should 
cause the energy of this transition to increase and hence 
reduce the magnitude of the paramagnetic shielding. 
The maximum complexation shifts were demonstrated by 
the N-methylpyrazole (III)-zinc chloride complex IX 
dissolved in chloroform and the ethyl 2-pyrazolylethanoate 
(IV)-zinc chloride complex X in acetonitrile. These N2-zinc 
shifts, +so.a and +54.9 ppm, respectively, are probably 
close to the shifts due to complete zinc cornplexation, as 
will be discussed later. However, the observed resonances 
may be in fact the averaged N2 resonances of complexed and 
uncomplexed pyrazole derivatives. It is therefore important 
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to subject the shifts of these model pyrazole-zinc complexes 
to close scrutiny before designating them to be those which 
correspond to full zinc complexation. 
While one might expect the upfield shift upon zinc 
complexation of a pyrazole N2 to be close to the reported 
protonation shifts, on the order of 100 ppm,54 the zinc 
cornplexation shifts of III and IV are about half that. Nee 
and Roberts69 report upfield shifts upon complexation of 
guanosine and cytidine by ki~-diarnmine-dichloroplatinum 
which were greater than the respective protonation shifts. 
However, the effect of platinum with its low-lying d 
orbitals in these square planar complexes is probably very 
different from the effect of zinc in the model pyrazole-zinc 
complexes. For pyridine-type nitrogens similar to N2 of 
pyrazole, all evidence supports the conclusion that zinc-
complexation shifts are about half the protonation shifts, 
though in the same direction. Alei and coworkers found this 
to be the case for zinc complexation of N-methylimidazole, 
where the zinc complexation shift of N3 is +35-40 ppm and 
the protonation shift is +73 ppm.66 
The stoichiometry of complexation, the extent of 
exchange between complexed and uncomplexed pyrazole, and the 
geometry of the complex should all affect the magnitude of 
the shielding caused by zinc complexation. 
66 
The number of pyrazoles per zinc in the crystalline N-
methylpyrazole-z inc chloride complex has been determined by 
atomic analysis to be two, the compound having been isolated 
before obtaining the lSN spectrum in chloroform. The 
coordination number of ethyl 2-pyrazolylethanoate to zinc in 
acetonitrile solution is not known. However, on the basis 
of the molar ratio of IV to zinc chloride at saturation, 
2:1.5, and on the assumption that ethyl 2-pyrazolylethanoate 
coordinates as a bidentate ligand as in Figure 12, it is 
expected that both IV-zinc and IV2-zinc complexes exist. 
The argument is that almost all the zinc chloride present 
must exist as ethyl 2-pyrazolylethanoate complexes, because 
the solubility of zinc chloride in neat acetonitrile is low. 
(If indeed the ester carbonyl group alone coordinates to 
zinc, the existence of the IV2-zinc complex is not required 
to explain the stoichiometry of the system.) The IV-zinc 
and rv2-zinc complexes must be in fast exchange because only 
one averaged N2 signal is observed. The actual shift 
difference between the two proposed IV complexes is not 
known. Alei and coworkers65 have estimated shift 
differences of up to about 10 ppm for imidazole-zinc 
complexes of varying stoichiometries in aqueous solution. 
The extent of exchange is hard to determine by NMR 
techniques if the exchange is fast on the NMR time scale, 
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resulting in one average N2 resonance. Only one N2 resonance 
is observed for each model system, indicating either fast 
exchange or slow exchange where the concentration of the 
uncomplexed species is too low to be observed. In the E-
methylpyrazole-z inc chloride complex IX, the extent of 
ligand exchange in chloroform solution is expected to be 
slight, if at all, because of the poor ability of chloroform 
to solvate zinc chloride and the shift observed for N2 of 
the N-methylpyrazole-zinc chloride complex should be that of 
the fully complexed nitrogen. 
The extent of exchange in the ethyl 2-
pyrazolylethanoate (IV)-zinc chloride systems in 
acetonitrile and dimethyl sulfoxide solutions is not as easy 
to est~mate. Acetonitrile and particularly dimethyl 
sulfoxide generally have much greater coordinating and 
ionizing abilities for cations than chloroform. While 
dissociation of pyrazole-zinc complexes has been found70 to 
be generally low in acetonitrile, it occurs sufficiently in 
the IV-zinc system to allow signal averaging of the 
complexed and uncornplexed nitrogens. Evidence for this is 
the observation, on addition of zinc chloride to produce a 
2:1 molar ratio of IV:zinc chloride, of one N2 resonance for 
IV in acetonitrile, which shifts upfield upon further 
addition of zinc chloride. However, the resonance observed 
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on addition of zinc chloride to produce a 2:1.S molar ratio 
may be at the position of fully complexed N2. At this 
saturating zinc chloride concentration, only a +2.6 ppm 
change in shift of N2 is seen compared to the shift observed 
at a 2:1 molar ratio. The contribution of N2 of uncomplexed 
IV to the observed shift is expected to be slight. 
In dimethyl sulfoxide solution, however, the case is 
different. The solubility of zinc chloride in neat dimethyl 
sulfoxide is much greater than in neat acetonitrile, where 
p r i o r a d d i t i on o f p y r a z o 1 e i s n e c e s s a r y ·t o ob t a i n 
appreciable zinc chloride concentrations. Dimethyl 
sulf oxide is a good zinc-coordinating agent, 71 effectively 
competing with pyrazole for zinc. The maximum shift 
observed for the zinc complex of ethyl 2-pyrazolylethanoate, 
+41.5 ppm, is 13.4 ppm less than that observed in 
acetonitrile. In dimethyl sulfoxide, again a single N2 
resonance is observed which is expected to be the weighted 
average resonance for N2 of complexed and uncomplexed 
pyrazole derivative. This resonance shifts upfield on 
further addition of zinc chloride. To reach saturation of 
zinc chloride, at least 4.5 moles of zinc chloride must be 
added to a 2 H solution of IV. As seen from the data in 
Table 6, the change in shift of N2 upon addition of zinc 
chloride has begun to level off at the molar ratio of 2:4.5 
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(IV:zinc chloride). However, because of the contribution of 
uncomplexed IV to the observed chemical shift and because of 
the high degree of participation of solvent in the 
complexation of the zinc, the IV-zinc chloride complex in 
dimethylsulfoxide is not likely to be a good model system 
for a fully complexed pyrazole and will not be used for 
comparison to the enzyme complex. 
The geometry of the N-methylpyrazole-zinc chloride 
complex in chloroform, in the absence of coordination of 
• 
solvent to zinc, is most likely tetrahedral, the proposed 
geometry of crystalline (pyrazole) 2 znc1 2 ,72 as illustrated 
in Figure 13, the solvent molecules being unable to 
coordinate to the metal. This is the expected geometry of 
the LADH-NAD+-pyrazole complex. If both the pyrazole 
nitrogen and the ester carbonyl coordinate to the zinc, the 
geometry of the proposed (ethyl 2-pyrazolylethanoate) 2-znc1 2 
(rv2-zinc) complex in acetonitrile should be octahedral, the 
preferred geometry of six-coordinate znII, the chloride ions 
not dissociating much in acetonitrile. The four-coordinate 
crystalline coII complex CN-carbamoylpyrazole)CoC1 2 is 
proposed to be a tetrahedral complex.73 Similarly, the mono 
IV-zinc complex in acetonitrile in the absence of solvent 
coordination should be tetrahedral. Acetonitrile is able to 
coordinate to zinc, as demonstrated by the conductance of 
71 
zinc perchlorate in acetonitrile.74 However, in the IV-zinc 
system in acetonitrile, it is not known to what extent 
solvent coordination occurs. 
72 
III.5. lSN ~ID~ Shifts .Q.f ~ ~m~ Ternary 
Complexes 
LAPH-NAP+-Pyrazole 
The chemical shift of the pyrrole-type nitrogen, Nl, of 
pyrazole in the LADH-NAD+-pyrazole complex is 142.1 ppm 
(Table 1). This is considerably downfield from Nl 
resonances of identified pyrazole derivatives (Table 2) 
other than the pyrazole-NAD+ model adduct, N-benzyl-1,4-
dihydro-4-pyrazolylnicotinamide, V, which has an Nl 
resonance of 136.3 ppm. As discussed earlier, the Nl shift 
of V seems characteristic of binding to dihydronicotinarnide. 
Therefore, the Nl shift of the LADH-NAD+-pyrazole complex is 
indicative of pyrazole Nl-nicotinamide complex formation 
within the active site of the enzyme through pyrazole 
addition to the nicotinamide ring. 
The site of addition of pyrazole to the nicotinamide 
ring in v has been reported by Angel is to be c4.29 Our NMR 
shifts of the ternary complex cannot be used to 
unambiguously assign the position where pyrazole binds to 
the nicotinamide ring. Other unidentified, minor (about 30% 
of the total) reaction products of pyrazole and E-
benzylnicotinamidinium chloride have Nl chemical shifts 
(Table 4) similar to those of the model pyrazole-NAD+ adduct 
V and the enzyme ternary complex. While these products with 
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similar Nl shifts may be the result of polymerization of V, 
they could also be the result of C2 or C6 addition to the 
nicotinamide ring. However, X-ray crystallographic studies 
of the LADH-NAD+-pyrazole complex demonstrate bond formation 
between Nl of pyrazole and C4 of the nicotinamide ring.9 
The pyrazole Nl chemical shift found for the enzyme 
complex is 5.8 ppm upfield from that found for the model 
adduct, probably because of the effect of a change in the 
substituent at the nicotinamide nitrogen and/or the effect 
of interaction with enzyme residues • . The effect of ribosyl 
substitution versus benzyl substitution at the nicotinamide 
nitrogen may be seen from a comparison of the 13c chemical 
shifts of NADH75 and E-benzyl-1,4-dihydronicotinamide.29 
The C4 resonance of NADH is shielded by 0.8 ppm relative to 
C4 of N-benzyl-1,4-dihydronicotinamide. The Nl chemical 
shift of pyrazole attached to C4 of the coenzyme should 
therefore be shielded with respect to that of pyrazole 
attached to C4 of the benzyldihydronicotinamide moiety, as 
actually occurs in the enzyme complex. Also contributing to 
the +5.8 ppm discrepancy ·could be the effects of a Nl-C4-
nicotinamide ring bond angle and bond distance in the enzyme 
complex which differ significantly from the model adduct 
because of constraints imposed by the active-site residues. 
Eklund and coworkers9 report a Nl-C4-nicotinamide ring bond 
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angle of about 90° and a Nl-C4 bond distance of 2 A for the 
crystal structure of LADH-NAD+-pyrazole determined at 2.9 A 
resolution. Both of these differ from that expected for the 
adduct in solution. The bond angle would be expected to be 
close to the tetrahedral value of 109.5° and the bond 
distance much shorter, by about 0.5 A. 
The pyridine-type nitrogen, N2, of pyrazole in the 
ternary complex has a chemical shift of 117.8 ppm (Table 1). 
This is 40-50 ppm upfield from the N2 chemical shifts of 
other pyrazoles in the absence of hydrogen bonding (Table 
2), 41.l ppm upfield from that of the pyrazole-NAD+ model 
adduct V (Table 1). The maximum upfield shift which can 
reasonably be ascribed to hydrogen bonding is about 18 ppm, 
based on the change in shift of +17.9 ppm for N2 of E-
methylpyrazole upon change of solvent from chloroform to 
trifluoroethano1.54 The only reasonable explanation for the 
more than 40 ppm shielding of the pyrazole N2 in the ternary 
complex relative to the model adduct is substantial 
complexation by the active-site zinc. 
Evidence in support of zinc_complexation of pyrazole in 
the ternary enzyme complex is provided by the shift changes 
upon zinc complexation of N-methylpyrazole, III, and ethyl 
2-pyrazolylethanoate, IV, 50.8 and 54.9 ppm upfield, 
respectively, for the N2 resonances in chloroform and 
75 
acetonitrile, respectively. The N2 shift changes of these 
model pyrazole-zinc complexes, CN-methylpyrazole)2ZnCl2 (IX, 
Figure 12) and the ethyl 2-pyrazolylethanoate-zinc complex 
(X, Figure 13) were 'the largest for various pyrazole-
derivative zinc complexes investigated (Table 5). (The 
instability of the model pyrazole-NAD+ adduct V in the 
presence of metal ions,29 was such that the effect of zinc 
cornplexation on its N2 chemical shift could not be 
determined.) 
The magnitude of the zinc complexation shift should be 
affected by the nature of the other ligands to zinc in the 
complex. In the enzyme, there are one histidine and two 
cysteine ligands to the catalytic zinc ion, which leaves a 
fourth coordination site open for complexation of solvent, 
substrate, or inhibitor. Among the model compounds, the 
second pyrazole in the H-methylpyrazole-zinc chloride adduct 
is an analog for the histidine residue, and chloride ion, a 
strongly associated ligand in non-nucleophilic solvents such 
as chloroform, is an analog for the cysteine residues. With 
the ethyl 2-pyrazolylethanoate-zinc chloride complex, 
dissolved in acetonitrile, the ester carbonyl group of ethyl 
2-pyrazolylethanoate may, or may not, be as good an analog 
for histidine as pyrazole. Furthermore, there could well be 
competition between chloride ion and acetonitrile for the 
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third and fourth ligand sites. Intuitively, the +so.a ppm 
lSN-complexation shift for the N-methylpyrazole-zinc complex 
could be a better estimate for the shift upon full zinc 
complexation than the +54.9 ppm for the ethyl 2-
pyrazolylethanoate-zinc complex. However, no definitive 
judgment can be made at this time. 
It is possible that in the LADH-NAD+-pyrazole complex 
there is fast exchange between a state where N2 of pyrazole 
is directly coordinated to zinc and a state where water or 
hydroxide ion is complexed to zinc and hydrogen bonded to N2 
of pyrazole, in effect, an inner sphere-outer sphere 
equilibration process. As will be discussed later, the 
linewidths of the observed nitrogens of the enzyme complex 
are narrow, in agreement with a high degree of mobility of 
the pyrazole moiety. If one takes the full zinc 
complexation shift to be 51-55 ppm, and the hydrogen-bonding 
shift to be 18 ppm, the +41 ppm N2 shift of the enzyme 
complex relative to the model adduct V indicates that the 
inner-sphere state contributes 60-70% to the whole. 
However, it should be noted that this · range of values 
approximates the lower limit of inner-sphere coordination of 
pyrazole to zinc in the ternary complex, and that it is 
possible that the +41 ppm N2 shift corresponds to full 
inner-sphere complexation. 
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If there is 100% inner-sphere coordination of pyrazole 
in the enzyme complex in solution, as in the crystalline 
complex,9 the fact that the zinc complexation shift 
determined for the enzyme is 10-14 ppm less than that 
determined for the model complexes could be attributed to 
differences in the nature of the ligands and the steric 
requirements of residues in the active site, as well as the 
nature of the substituent at Nl. 
LAPH-NAD+-4-Ethylpyrazole 
The LADH-NAo+-4-ethylpyrazole complex was prepared to 
determine the effect that tighter binding of inhibitor has 
on the Nl and N2 resonances of the pyrazole nucleus. The 
inhibition constant in the presence of NAO+ of 4-
ethylpyrazole, structure II, is almost 30 times smaller 
than that of pyrazole (K 1=0.007 and 0.2 pM, respectively). 
Alkyl substituents at the 4-position increase the stability 
of pyrazole-inhibitor complexes because of interactions 
between the substituent and the hydrophobic cleft of the 
substrate-binding region of the enzyme. While the substrate 
complex containing the 4-iodopyrazole (KI=0.02 pM27) was 
found by X-ray crystallography to -have a structure which is 
very similar to that of the complex containing pyrazole 
itself, these hydrophobic interactions may lead to a 
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conformation of the pyrazole nucleus in the 4-ethylpyrazole 
complex which differs from that of the pyrazole complex. 
The Nl chemical shift of the ternary complex should reflect 
changes in the Nl-C4 bond distance and angle to the 
nicotinamide ring. The N2 chemical shift should be affected 
by changes in the N2-zinc .bond distance and changes in the 
inner sphere-outer sphere equilibrium, if any. 
Our lSN shifts indicate that the structure of the LADH-
NAD+-4-ethylpyrazole complex is very similar to that of the 
LADH-NAD+-pyrazole complex (Table 1). The Nl chemical shift 
in the 4-ethylpyrazole complex, 146.0 ppm, is 3.9 ppm 
upfield from that of the pyrazole complex, possibly as the 
result of substitution at the 4-position of pyrazole and of 
small changes in geometry about the Nl-C4 bond. The N2 
chemical shift in the 4-ethylpyrazole complex, 119.0 ppm, is 
1.2 ppm upfield from that of the pyrazole complex. This is 
a small change, but it is in the direction of greater zinc 
complexation. 
Another way to look at this is to compare the 
dif.ferences between average nitrogen shifts in the enzyme 
co~plexes to the difference between the averaged nitrogen 
shift in the free inhibitors. When this is done, the effect 
of substitution at the 4-position is expected to cancel and 
shifts may be analyzed for other effects. The average of 
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these nitrogen shifts in the 4-ethylpyrazole enzyme complex, 
13 2.5 ppm, is 2.55 ppm upfield from the ave rage in the 
pyrazole enzyme complex, while the chemical shift of free 4-
ethylpy ra zol e is only 1.6 ppm upfield from that of free 
pyrazole. This result is consistent with somewhat greater 
zinc complexation in the 4-ethylpyrazole enzyme complex. 
This could be because of a small decrease in the N2-zinc 
bond distance and/or a small shift in an inner sphere-outer 
sphere equilibrium toward greater inner-sphere 
coordination. 
IV. 15N NMB Lin.ewidths 
LAPH-NAP+-Pyrazo~ ~QID~ 
The observed linewidths for the nitrogen resonances of 
the LADH-NAD+-pyrazole complex are surprisingly narrow for a 
complex presumably of MW over 80,000. The linewidths 
collected in Table 8 include those of the pyrazole nitrogen 
doublets. The non-equivalent pyrazole nitrogens in the 
complex are coupled with an observed lJNN of 10±2 Hz, which 
means the actual observed linewidths of the individual 
resonances are 10 Hz less than those of the incompletely 
resolved doublets. The resonances do not arise from low-
rnolecular-weight materials present in solution because the 
Table 8. 15N Linewidthsa of the Enzyme Ternary Complexes 











50.6 8 30±2d 
50.68 40±7d 
a Observed line width at half-height. 





c (linewidth of doublet) 1 - ( JNN of 10 H3) 
d One-bond 15N-15N coupling unresolved. 
e 1JNN not determined. 
Pyrazole Nl 
doublet actualc NADR 
16±2 -6 





Figure 14 • P 1 ot of L inew id th, .Vy'" , ye rs us Effective 
Correlation Time, 1:"' eff' Assuming Dipolar Relaxation 
(from reference 77). 
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complex from which they arise is not dialyzed. 
For high-molecular-weight substances, a narrow 
linewidth necessarily implies a high degree of mobility of 
the nucleus from which the resonance arises.76 Clearly, the 
effective correlation times for the pyrazole and 
nicotinarnide portions of the inhibitor complex are much 
shorter than that expected for the bulk of the enzyme, 
despite the apparent tightness of bonding of the inhibitor 
to the coenzyme and catalytic zinc. 
McGrath7 7 has estimated the rotational correlation time 
for LADH to be 4.6 x 10-8 sec, using the Stokes-Einstein 
equation for an ellipsoid molecule of MW 80,000. A rough 
estimate of the correlation time may be obtained from the 
transverse relaxation time, T2• T2 may be calculated from 




When T2 is calculated using the observed linewidth, a lower 
limit to the actual transverse relaxation time is obtained 
because contributions to the linewidth from magnet 
inhomogeneity, residual spin-spin coupling or chemical 
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exchange possibly present have been ignored.31 The values 
of T2 calculated in this manner for pyrazole Nl and N2 of 
LAD H - NA D + - p y r a z 0 l e a t 1 8 • 2 5 M H z 1) 1/1,,. = 6 a n d 1 0 H z , 
respectively) are 0.053 and 0.032 sec, respectively. 
If it is assumed at this magnetic field that the 
relaxation mechanism is mainly dipolar, and the effective 
correlation time is less than about io-8 sec-1, then T2 is 
equal to the dipolar longitudinal relaxation time T1, and 
t~e effective correlation time, 'C eff' may be calculated 
from the equation31 
1 
't' eff = • 
The assumption of domination of the dipolar relaxation 
mechanism may not be an especially good one, because of the 
possibility of chemical-shift anisotropy (CSA) relaxation. 
However, as discus~ed later, CSA is estimated to make 
contributions of no more than about 30% and 25% to T2 of Nl 
and N2. For Nl and N2 at 18.25 MHz, the effective 
correlation times estimated in this way are 4.6 x 10-9 and 
7.6 x io-9 sec, respectively. These numbers are similar to 
those estimated from a plot of linewidth ~~~~Y~ effective 
correlation time for situations where dipolar relaxation 
dominates, illustrated in Figure 14 and taken from reference 
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77. From this plot, the effective correlation times of Nl 
and N2 at 42 kGauss (18.25 MHz) are estimated to be 2 x io-9 
and 5 x io-9 sec, respectively. 
The effective correlation time for Nl is thus roughly 
estimated to be an order of magnitude shorter than that of 
the enzyme considered as a whole. Gust, Moon and Roberts33 
determined an effective correlation time of 3.5 x io-9 sec 
for the guanidino NHi+ groups based on 15N T1 and NOE 
measurements, for lysozyme (MW 14,300), which has an 
estimated effective correlation as a whole of 5 x lo-9 sec. 
This difference is comparable to the difference between the 
correlation times of pyrazole Nl and LADH considered as a 
whole, indicating a degree of internal mobility of Nl 
similar to the guanidino NH2+ groups. 
The narrow lines observed for the pyrazole and 
nicotinamide nitrogens of the LADH-NAD+-pyrazole complex 
thus indicate that the structure of the complex is unlikely 
to be very rigid and it is possible that there is fast 
exchange between inner-sphere and outer-sphere coordination 
states of N2 of pyrazole to the active-site zinc. It is 
also possible that the resonances are narrow because of an 
unexpected flexibility of the pyrazole and nicotinamide 
moieties while maintaining direct coordination of N2 to the 
zinc. In the crystalline complex, there appears to be 
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sufficient room in the substrate-binding pocket for the 
pyrazole nucleus to rotate ±20° around the N2-zinc axis, 9 
but it is not clear whether this is enough to give the sharp 
lSN lines. 
The mobility of the nicotinamide nitrogen may be 
explained in part by the fact that the nicotinamide moiety 
of binary LADH-coenzyme comlexes is not very tightly bound, 
as evidenced by the observation that ADPR binds almost as 
strongly as NADH and more strongly than NAD+.2 The 
observation of this sharp lSN resonance suggests that lSN 
NMR of other enzyme-[Nl-lSN]-NAD+ complexes may prove 
fruitful. 
LADH-NAD+-4-Ethylpyra~ ~m~ 
The linewidths of the LADH-NAD+-4-ethylpyrazole complex 
indicate less mobility of the pyrazole nucleus in the 4-
ethylpyrazole complex than in the LADH-NAD+-pyrazole complex 
(Table 8). The linewidth at 50.68 MHz was 40 Hz, one-third 
greater than that found in the pyrazole complex, w .hi~e the 
Nl linewidth was about the same in both complexes. This can 
be explained if the 4-ethylpyrazole-enzyme residue 
interactions restrict mobility of N2 but not Nl, and/or if 
the N2-zinc interaction is stronger than in the pyrazole 
complex, slightly immobilizing N2. This latter case would 
86 
contribute to the overall greater stability of the inhibitor 
complex and would explain the upfield shift of N2 relative 
to the pyrazole complex. 
Field Effects 
In 15N NMR, in the absence of paramagnetic species and 
nuclear quadrupoles, the major mechanism of relaxation is 
often dipolar, but relaxation due to chemical-shift 
anisotropy {CSA) can be important, especially for sp- and 
sp2-hybridized nitrogens.31 If the relaxation of the 
observed nucleus is purely dipolar, then the linewidth of 
the resonance is predicted to decrease with increasing 
magnetic field, eventually becoming field-independent in the 
high-field limit.37 However, when CSA contributes to the 
relaxation mechanism, the linewidth is field-dependent, the 
anisotropic contribution to T2 being inversely proportional 
to the square of the field, and the associated linewidth 
increasing quadratically as the field is increased.37 The 
linewidths of Nl and N2 of the LADH-NAD+-pyrazole complex 
are observed to increase as the spectrometer frequency is 
increased from 18.25 to 50.68 MHz. The increase in field is 
2.78-fold and the square of this increase is 7.7. The Nl 
and N2 linewidths only increase 2.5-fold and 2-fold, 
respectively, indicating at the most a one-third and one-
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fourth contribution of CSA to the spin-spin relaxation. The 
observed increase in linewidth can reasonably be attributed 
to chemical-shift anisotropy broadening, but could also be 
caused by chemical-exchange broadening, which is also field-
dependent. The occurrence of an equilibrium involving inner 
sphere-outer sphere zinc complexation of pyrazole could 
therefore contribute to the line-broadening at a higher 
field. 
The sharp lines observed for the enzyme complex at 
18.25 MHz indicate that if chemical exchange is occurring, 
it is fast on the NMR time scale, and the rate, k, is much 
greater than 2 times the separation in Hertz of the two 
exchanging resonances, that is, 
k > 2 lt' AV or k > 2n'CAS x 18.25 MHz) 
where the separation in Hertz equals the chemical-shift 
d i ff ere n c e in ppm ( AS ) t i mes the f i el d in Hert z. For 
exchange between fully hydrogen-bonded and zinc-complexed 
pyrazole, there should be a shift difference of about 33 
ppm, which means an exchange rate greater than 3.8 x 103 
sec-1. The line broadening at 50.68 MHz would be consistent 
with an intermediate exchange rate, that is, approaching 
k ~ 2 tr'( A& x 50.6 8 MHz) ,,..,, 1.1 x 104 sec-1. 
Because this rate is being approached from the fast exchange 
limit, it is a lower limit to the exchange rate. This 
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calculation of the possible rate of exchange between inner 
sphere- and outer sphere-coordination of pyrazole by the 
active-site zinc is of course only valid if the line 
broadening at high field is in fact caused by chemical 
exchange and not CSA. 
v. Relevance t..Q Mechanism Qf LAllH 
The structure of the LADH-NAD+-pyrazole complex may 
provide insight into the role of the zinc ion in binding and 
activation of substrate. Our lSN results indicate that, in 
solution, the active site of the enzyme promotes the 
formation of an entity where pyrazole is substantially 
directly coordinated to the active-site zinc and also 
covalently bound to the nicotinamide moiety. The structure 
of the LADH-NAD+-pyrazole complex (Figure 15 ) is very 
similar to the proposed structurel,2 of the transition 
state of the LADH reaction where substrate is inner-sphere 
coordinated to zinc (Figure 16). The zinc may thus help to 
orient the substrate within the substrate-binding pocket 
correctly in relation to the nicotinamide moiety for 
stereospecif ic hydride transfer to occur, while at the same 




Figure fgN• Proposed Structure of LADH-NAD+-Pyrazple, Based 
on NMR Results, Indicating Substantial (60-100%) 
Direct Zinc Complexation. 
Figure 16. Proposed Structure of the Transition State of 
the LADH Oxidation of Alcohol. 
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Direct zinc-coordination of alcohol substrate would 
decrease its pKa, possibly to a point where substrate binds 
as the alcoholate as previously proposed,1,2 thus 
facilitating transfer of hydride from substrate to NAD+. In 
the reverse reaction, polarization of the carbonyl group of 
aldehyde substrate by the active-site zinc would create 
partial positive charge on Cl, facilitating hydride transfer 
from NADH to substrate. X-ray crystallographic studies7- 9 
have supported this mechanism by indicating direct 
coordination of substrate or inhibitor to zinc. However, 
because the crystal structures may differ from the solution 
structures, it is significant that our results demonstrate a 
structure of LADH-NAD+-pyrazole in solution which is similar 
to the crystal structure. 
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CONCLUSIONS 
We have found that in solution, the LADH-NAD+-pyrazole 
complex has chemical shifts for the pyrazole Nl and 
nicotinamide ring nitrogens which suggest bond formation 
between pyrazole Nl and nicotinamide C4, in agreement with 
the model first proposed by Theorell and Yonetani.24 The 
chemical shift of the pyrazole N2 for the ternary complex is 
indicative of substantial (60-100%) inner-sphere 
coordination to the active-site zinc. While these results 
do not exclude partial outer-sphere coordination, they do 
demonstrate that the solution structure of the ternary 
complex (Figure 15) is very similar to that found for the 
crystalline enzyme complex. 
The LADH-NAD+-4-ethylpyrazole complex was found to be 
very similar in structure to the LADH-NAD+-pyrazole complex, 
with possibly slightly stronger coordination of N2 to the 
active-site zinc. 
This is the largest enzyme complex {MW over 80,000) for 
which lSN spectra have been reported. The narrow 15 N 
resonances observed for the LADH-NAD+-pyrazole complex are 
noteworthy for such a high-molecular-weight complex. It 
would appear that the application of NMR to the general 
investigation of small molecules bound to large biomolecules 
should not be prejudged to give such broad lines as to be 
worthless to attempt. 
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